Preview

Качественная клиническая практика

Расширенный поиск

Тератогенное действие ингибиторов АПФ в I триместре беременности

Полный текст:

Аннотация

Описано возможное тератогенное действие ингибиторов АПФ на плод в I триместре беременности.

Об авторах

А. Н. Грацианская
ФГБОУ ВО РНИМУ им. Н.И. Пирогова; ФГБУ РДКБ МЗ РФ
Россия
кафедра клинической фармакологии с курсом клинической фармакологии и фармакокинетики ФУВ


М. Н. Костылева
ФГБОУ ВО РНИМУ им. Н.И. Пирогова; ФГБУ РДКБ МЗ РФ
Россия
кафедра клинической фармакологии с курсом клинической фармакологии и фармакокинетики ФУВ


Список литературы

1. Khedun S.M., Maharaj B., Moodley J. Effects of antihypertensive drugs on the unborn child. What is known, and how should this influence prescribing? Paediatr Drugs 2000; 2: 419-436.

2. Magee L.A. Treating hypertension in women of child-bearing age and during pregnancy. Drug Safety 2001; 24: 457-474.

3. Zhang J., Meikle S., Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003; 22: 203-212.

4. Afifi Y., Churchill D. Pharmacological treatment of hypertension in pregnancy. Curr Pharm Des 2003; 9: 1745-1753.

5. Opie L.H. Angiotensin converting enzyme inhibitors. The advance continues. 3 edition. Authors' Publishing House, New-York, 1999; 275.

6. Briggs G.G. Drug effects on the fetus and breast-fed infant. Clin Obstet Gynecol 2002; 45: 6-21.

7. Tabacova S., Little R., Tsong Y., Vega A., Kimmel C.A. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol Drug Saf 2003; 12: 633646.

8. Martin R.A., Jones K.L., Mendoza A., Barr M. Jr., Benirschke K. Effect of ACE inhibition on the fetal kidney: decreased renal blood flow. Teratology 1992; 46: 317-321.

9. Bhatt-Mehta V., Deluga K.S. Fetal exposure to lisinopril: neonatal manifestations and management. Pharmacotherapy 1993; 13: 515-518.

10. Moore K.L., Persaud T.V.N. The developing human: clinically oriented embryology. 5th ed. Philadelphia: W.B. Saunders, 1993.

11. Briggs G.G. Drug effects on the fetus and breast-fed infant. Clin Obstet Gynecol 2002; 45: 6-21.

12. Steffensen F.H., Nielsen G.L., Sorensen H.T., Olesen C., Olsen J. Pregnancy outcome with ACE-inhibitor use in early pregnancy. Lancet 1998; 351: 596-596.

13. Yip S.K., Leung T.N., Fung H.Y. Exposure to angiotensin-converting enzyme inhibitors during first trimester: is it safe to fetus? Acta Obstet Gynecol Scand 1998; 77: 570-571.

14. Lip G.Y., Churchill D., Beevers M., Auckett A., Beevers D.G. Angiotensin-converting-enzyme inhibitors in early pregnancy. Lancet 1997; 350: 1446-1447.

15. Chisholm C.A., Chescheir N.C., Kennedy M. Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure. Am J Perinatol 1997; 14: 511-513.

16. Hu F., Morrissey P., Yao J., Xu Z. Development of AT(1) and AT(2) receptors in the ovine fetal brain. Brain Res Dev Brain Res 2004; 150: 51-61.

17. Burrell J.H., Hegarty B.D., McMullen J.R., Lumbers E.R. Effects of gestation on ovine fetal and maternal angiotensin receptor subtypes in the heart and major blood vessels. Exp Physiol 2001; 86: 71-82.

18. Cooper W.O., Hernandez-Diaz S., Arbogast P.G. et al. Major Congenital Malformations after First-Trimester Exposure to ACE Inhibitors, NEJM, 2006, Vol. 354: 2443-2451.

19. ACE Inhibitors and Birth Defects: Unsafe in Any Trimester. JWatch Women's Health 2006: 1-1.


Для цитирования:


Грацианская А.Н., Костылева М.Н. Тератогенное действие ингибиторов АПФ в I триместре беременности. Качественная клиническая практика. 2006;(2):76-79.

For citation:


., . . Kachestvennaya klinicheskaya praktika. 2006;(2):76-79. (In Russ.)

Просмотров: 133


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2588-0519 (Print)
ISSN 2618-8473 (Online)